Abstract
Background: Radiation is the fourth most prevalent type of pollution following the water, air and noise pollution. It can adversely affect normal bodily functions. Radiation alters the protein and mRNA expression of drugmetabolizing enzymes and drug transporters and the pharmacokinetic characteristics of drugs, thereby affecting drug absorption, distribution, metabolism, and excretion. Therefore, it is important to study the pharmacokinetic changes in drugs under radiation.
Methods: To update data on the effects of ionizing radiation and non-ionizing radiation caused by environmental pollution or clinical treatments on the protein and mRNA expression of drug-metabolizing enzymes and drug transporters. Data and information on pharmacokinetic changes in drugs under radiation were analyzed and summarized.
Results: The effect of radiation on cytochrome P450 is still a subject of debate. The widespread belief is that higherdose radiation increased the expression of CYP1A1 and CYP1B1 of rat, zebrafish or human, CYP1A2, CYP2B1, and CYP3A1 of rat, and CYP2E1 of mouse or rat, and decreased that of rat’s CYP2C11 and CYP2D1. Radiation increased the expression of multidrug resistance protein, multidrug resistance-associated protein, and breast cancer resistance protein. The metabolism of some drugs, as well as the clearance, increased during concurrent chemoradiation therapy, whereas the half-life, mean residence time, and area under the curve decreased. Changes in the expression of cytochrome P450 and drug transporters were consistent with the changes in the pharmacokinetics of some drugs under radiation.
Conclusion: The findings of this review indicated that radiation caused by environmental pollution or clinical treatments can alter the pharmacokinetic characteristics of drugs. Thus, the pharmacokinetics of drugs should be rechecked and the optimal dose should be re-evaluated after radiation.
Keywords: Radiation, pharmacokinetics, characteristics, drug-metabolizing enzyme, cytochrome P450, drug transporters.
Graphical Abstract
[1]
Christensen, D.M.; Jenkins, M.S.; Sugarman, S.L.; Glassman, E.S. Management of ionizing ratidatio injuries and illnesses, part 1: Physics, radiation protection, and radiation instrumentation. J. Am. Osteopath. Assoc., 2014, 114, 189-199.
[2]
Christensen, D.M.; Livingston, G.K.; Sugarman, S.L.; Parillo, S.J.; Glassman, E.S. Management of ionizing radiation injuries and illnesses, Part 3: Radiobiology and health effects of ionizing radiation. J. Am. Osteopath. Assoc., 2014, 114, 556-565.
[3]
Sun, Q. Mao, W.; Jiang, H.; Zhang, X.; Xiao, J.; Lian, Y. The Effect of Protracted exposure to radiation on liver injury: A cohort study of industrial radiographers in Xinjiang, China. Int. J. Environ. Res. Public Health, 2018, 15, 71-82.
[4]
Duan, Y.B.; Yao, X.C.; Zhu, J.B.; Li, Y.F.; Zhang, J.L.; Qiao, Y.J.; Yang, M.; Li, X.Y. Effect of yak-activated protein on hematopoiesis and related cytokines in radiation-induced injury in mice. Exp. Ther. Med., 2017, 14, 5297-5304.
[5]
Duan, Y.B.; Chen, F.; Yao, X.C.; Zhu, J.B.; Wang, C.; Zhang, J.L.; Li, X.Y. Protective effect of Lycium ruthenicum Murr. against radiation injury in mice. Int. J. Environ. Res. Public Health, 2015, 12, 8332-8347.
[6]
Shimizu, Y.; Iida, H.; Nenoi, M. Trends of training courses conducted in the human resources development center of the national institute for quantum and radiological science and technology after the Fukushima Dai-Ichi nuclear power plant accident. Health Phys., 2017, 113, 66-70.
[7]
Qiao, Y.J.; Xin, Y.Y.; Zhou, X.J.; Yang, M.; Li, X.Y. A review of radiation impact on drug metabolism. Acta Pharmacol. Sin., 2017, 52, 871-878.
[8]
Rendic, S.; Guengerich, F.P. Summary of information on the effects of ionizing and non-ionizing radiation on cytochrome P450 and other drug metabolizing enzymes and transporters. Curr. Drug Metab., 2012, 13, 787-814.
[9]
Rendic, S.; Guengerich, F.P. Update information on drug metabolism systems-2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters. Curr. Drug Metab., 2010, 11, 4-84.
[10]
Andrianov, A.; Kanke, V.; Kuptsov, I.; Murogov, V. Reexamining the ethics of nuclear technology. Sci. Eng. Ethics, 2015, 21, 999-1018.
[11]
Maksymchuk, O.V.; Bobyk, V.I.; Sydoryk, L.L.; Chashchyn, M.O. Influence of long-term combined gamma-radiation and ethanol on cytochrome P450 2E1 expression in the mice liver. Ukr. Biokhim. Zh., 2008, 80, 105-111.
[12]
Chung, H.C.; Kim, S.H.; Lee, M.G.; Cho, C.K.; Kim, T.H.; Lee, D.H.; Kim, S.G. Mitochondrial dysfunction by gamma-irradiation accompanies the induction of cytochrome P450 2E1 (CYP2E1) in rat liver. Toxicology, 2001, 161, 79-91.
[13]
Yi, J.F.; Wu, B.; Liu, C.L.; Gao, Y. Effect of ginsenoside total saponinon on regulation of P450 of livers of rats after γ-ray irradiation. Zhongguo Zhongyao Zazhi, 2015, 40, 4037-4043.
[14]
Mo, L.F. Study on the effect of low dose rate 60Co γ/neutron irradiation on the rats. PhD Thesis, The Second Military Medical University: Shanghai,. 2012.
[15]
Marchenko, M.M.; Kopyl’chuk, G.P.; Ketsa, O.V. Effect of low doses of x-ray irradiation on the liver detoxication system in rats with transplanted Guerin’s carcinoma. Biomed. Khim., 2010, 56, 266-273.
[16]
Qiao, Y.J. Effects of X-ray on the pharmacokinetics of irinotecan hydrochloride., Master Thesis, Qinghai University: Xining,. 2018.
[17]
Pasanen, M.; Lang, S.; Kojo, A.; Kosma, V.M. Effects of simulated nuclear fuel particles on the histopathology and CYP enzymes in the rat lung and liver. Environ. Res., 1995, 70, 126-133.
[18]
Choi, Y.H.; Lee, Y.S.; Kim, T.K.; Lee, B.Y.; Lee, M.G. Faster clearance of mirodenafil in rats with acute renal failure induced by uranyl nitrate: Contribution of increased protein expression of hepatic CYP3A1 and intestinal CYP1A1 and 3A1/2. J. Pharm. Pharmacol., 2009, 61, 1325-1332.
[19]
Souidi, M.; Gueguen, Y.; Linard, C.; Dudoignon, N.; Grison, S.; Baudelin, C.; Marquette, C.; Gourmelon, P.; Aigueperse, J.; Dublineau, I. In vivo effects of chronic contamination with depleted uranium on CYP3A and associated nuclear receptors PXR and CAR in the rat. Toxicology, 2005, 214, 113-122.
[20]
Guéguen, Y.; Souidi, M.; Baudelin, C.; Dudoignon, N.; Grison, S.; Dublineau, I.; Marquette, C.; Voisin, P.; Gourmelon, P.; Aigueperse, J. Short-term hepatic effects of depleted uranium on xenobiotic and bile acid metabolizing cytochrome P450 enzymes in the rat. Arch. Toxicol., 2006, 80, 187-195.
[21]
Ahn, C.Y.; Kim, E.J.; Lee, I.; Kwon, J.W.; Kim, W.B.; Kim, S.G.; Lee, M.G. Effects of glucose on the pharmacokinetics of intravenous chlorzoxazone in rats with acute renal failure induced by uranyl nitrate. J. Pharm. Sci., 2003, 92, 1604-1613.
[22]
Lee, M.G.; Lee, J.H.; Oh, J.M. Pharmacokinetic changes of drugs in rat model of acute renal failure induced by uranyl nitrate: correlation between drug metabolism and hepatic microsomal cytochrome P450 isozymes. Curr. Clin. Pharmacol., 2006, 1, 193-205.
[23]
Chung, W.; Kim, E.J.; Lee, I.; Kim, S.G.; Lee, M.G.; Kim, S.H. Effects of recombinant human growth hormone on the pharmacokinetics of intravenous chlorzoxazone in rats with acute renal failure induced by uranyl nitrate. Life Sci., 2003, 73, 253-263.
[24]
Souidi, M.; Tissandie, E.; Grandcolas, L.; Grison, S.; Paquet, F.; Voisin, P.; Aigueperse, J.; Gourmelon, P.; Guéguen, Y. Chronic contamination with 137cesium in rat: Effect on liver cholesterol metabolism. Int. J. Toxicol., 2006, 25, 493-497.
[25]
Racine, R.; Grandcolas, L.; Blanchardon, E.; Gourmelon, P.; Veyssiere, G.; Souidi, M. Hepatic cholesterol metabolism following a chronic ingestion of cesium-137 starting at fetal stage in rats. J. Radiat. Res., 2010, 51, 37-45.
[26]
Tissandie, E.; Guéguen, Y.; Lobaccaro, J.M.; Aigueperse, J.; Gourmelon, P.; Paquet, F.; Souidi, M. Chronic contamination with 137cesium affects vitamin D3 metabolism in rats. Toxicology, 2006, 225, 75-80.
[27]
Tissandie, E.; Gueguen, Y.; Lobaccaro, J.M.; Grandcolas, L.; Grison, S.; Aigueperse, J.; Souidi, M. Vitamin D metabolism impairment in the rat’s offspring following maternal exposure to 137 cesium. Arch. Toxicol., 2009, 83, 357-362.
[28]
Obolenskaya, M.Y.; Teplyuk, N.M. Divi. R.L.; Poirier, M.C.; Filimonova, N.B.; Zadrozna, M.; Pasanen, M.J. Human placental glutathione S-transferase activity and polycyclic aromatic hydrocarbon DNA adducts as biomarkers for environmental oxidative stress in placentas from pregnant women living in radioactivity- and chemically-polluted regions. Toxicol. Lett., 2010, 196, 80-86.
[29]
Zhou, X.J.; Nian, Y.Q.; Qiao, Y.J.; Yang, M.; Xin, Y.Y.; Li, X.Y. Hypoxia plays a key role in the pharmacokinetic changes of drugs at high altitude. Curr. Drug Metab., 2018, 19, 960-969.
[30]
Li, X.Y.; Wang, X.J.; Li, Y.P.; Yuan, M.; Zhu, J.B.; Su, X.D.; Yao, X.C.; Fan, X.R.; Duan, Y.B. Effect of exposure to acute and chronic high altitude hypoxia on the activity and expression of CYP1A2, CYP2D6, CYP2C9, CYP2C19 and NAT2 in rats. Pharmacology, 2014, 93, 76-83.
[31]
Behrendt, L.; Jönsson, M.E.; Goldstone, J.V.; Stegeman, J.J. Induction of cytochrome P450 1 genes and stress response genes in developing zebrafish exposed to ultraviolet radiation. Aquat. Toxicol., 2010, 98, 74-82.
[32]
Goerz, G. Barnstorf, W.; Winnekendonk, G.; Bolsen, K.; Fritsch, C.; Kalka, K.; Tsambaos, D. Influence of UVA and UVB irradiation on hepatic and cutaneous P450 isoenzymes. Arch. Dermatol. Res., 1996, 289, 46-51.
[33]
Katiyar, S.K.; Matsui, M.S.; Mukhtar, H. Ultraviolet-B exposure of human skin induces cytochromes P450 1A1 and 1B1. J. Invest. Dermatol., 2000, 114, 328-333.
[34]
Wei, Y.D.; Rannug, U.; Rannug, A. UV-induced CYP1A1 gene expression in human cells is mediated by tryptophan. Chem. Biol. Interact., 1999, 118, 127-140.
[35]
Luecke, S.; Wincent, E.; Backlund, M.; Rannug, U.; Rannug, A. Cytochrome P450 1A1 gene regulation by UVB involves crosstalk between the aryl hydrocarbon receptor and nuclear factor kappaB. Chem. Biol. Interact., 2010, 184, 466-473.
[36]
Feng, Y.; Liu, K.X. Research advances in organic anion transporter. Acta Pharm. Sin., 2016, 51, 1054-1059.
[37]
Liu, Q.; Liu, K.X. Advances in the study of enzymes and transporters-mediated pharmacokinetic mechanism for herb-drug interaction. Acta Pharm. Sin., 2015, 50, 406-412.
[38]
Zakeri-Milani, P.; Valizadeh, H. Intestinal transporters: Enhanced absorption through P-glycoprotein-related drug interactions. Expert Opin. Drug Metab. Toxicol., 2014, 10, 859-871.
[39]
Farcy, E.; Voiseux, C.; Robbes, I.; Lebel, J.M.; Fievet, B. Effect of ionizing radiation on the transcription levels of cell stress marker genes in the pacific oyster Crassostrea gigas. Radiat. Res., 2011, 176, 38-48.
[40]
Westover, D.; Li, F. New trends for overcoming ABCG2/BCRP-mediated resistance to cancer therapies. J. Exp. Clin. Cancer Res., 2015, 34, 159-168.
[41]
Ingram, W.J.; Crowther, L.M.; Little, E.B.; Freeman, R.; Harliwong, I.; Veleva, D.; Hassall, T.E.; Remke, M.; Taylor, M.D.; Hallahan, A.R. ABC transporter activity linked to radiation resistance and molecular subtype in pediatric medulloblastoma. Exp. Hematol. Oncol., 2013, 2, 26-43.
[42]
Christiansen, H.; Batusic, D.; Saile, B.; Hermann, R.M.; Dudas, J.; Rave-Frank, M.; Hess, C.F.; Schmidberger, H.; Ramadori, G. Identification of genes responsive to gamma radiation in rat hepatocytes and rat liver by cDNA array gene expression analysis. Radiat. Res., 2006, 165, 318-325.
[43]
Bottke, D.; Koychev, D.; Busse, A.; Heufelder, K.; Wiegel, T.; Thiel, E.; Hinkelbein, W.; Keilholz, U. Fractionated irradiation can induce functionally relevant multidrug resistance gene and protein expression in human tumor cell lines. Radiat. Res., 2008, 170, 41-48.
[44]
Bartkowiak, D.; Stempfhuber, M.; Wiegel, T.; Bottke, D. Radiation- and chemoinduced multidrug resistance in colon carcinoma cells. Strahlenther. Onkol., 2009, 185, 815-820.
[45]
Zhang, G.J.; Gao, R.; Wang, J.S.; Fu, J.K.; Zhang, M.X.; Jin, X. Various doses of fractioned irradiation modulates multidrug resistance 1 expression differently through hypoxia-inducible factor 1 in esophageal cancer cells. Dis. Esophagus, 2011, 24, 481-488.
[46]
Tsang, T.Y.; Tsang, S.W.; Lai, K.P.; Tsang, W.P.; Co, N.N.; Kwok, T.T. Facilitation of drug resistance development by gamma irradiation in human cancer cells. Oncol. Rep., 2009, 22, 921-926.
[47]
Bart, J.; Nagengast, W.B.; Coppes, R.P.; Wegman, T.D.; Van Der Graaf, W.T.; Groen, H.J.; Vaalburg, W. De Vries, E.G.; Hendrikse, N.H. Irradiation of rat brain reduces P-glycoprotein expression and function. Br. J. Cancer, 2007, 97, 322-326.
[48]
Mima, T.; Toyonaga, S.; Mori, K.; Taniguchi, T.; Ogawa, Y. Early decrease of P-glycoprotein in the endothelium of the rat brain capillaries after moderate dose of irradiation. Neurol. Res., 1999, 21, 209-215.
[49]
Li, X.F.; Ma, L.; Lu, J.; Kong, L.X.; Long, X.H.; Liao, S.H.; Chi, B.R. Effect of ionizing radiation on transcription of colorectal cancer MDR1 gene of HCT-8 cells. Asian Pac. J. Trop. Med., 2013, 6, 407-409.
[50]
Korystov, Y.N.; Shaposhnikova, V.V.; Korystova, A.F.; Emel’yanov, M.O.; Kublik, L.N. Modification of multidrug resistance of tumor cells by ionizing radiation. Cancer Chemother. Pharmacol., 2008, 61, 15-21.
[51]
Ji, X.N.; Yang, F.; Sui, X.M.; Wang, F.G.; Ge, R.G.; Quan, X.L.; Zhao, T.; Gao, B.W.; Wang, R.Y. Effect of fractionated irradiation on the expression of multidrug resistance genes in the CNE1 human nasopharyngeal carcinoma cell line. Mol. Med. Rep., 2013, 7, 187-194.
[52]
Trog, D.; Moenkemann, H.; Haertel, N.; Schüller, H.; Golubnitschaja, O. Expression of ABC-1 transporter is elevated in human glioma cells under irradiation and temozolomide treatment. Amino Acids, 2005, 28, 213-219.
[53]
Legendre, A.; Elie, C.; Ramambason, C.; Manens, L.; Souidi, M.; Froment, P.; Tack, K. Endocrine effects of lifelong exposure to low-dose depleted uranium on testicular functions in adult rat. Toxicology, 2016, 368-369, 58-68.
[54]
Lestaevel, P.; Bensoussan, H.; Racine, R.; Airault, F.; Gourmelon, P.; Souidi, M. Transcriptomic effects of depleted uranium on acetylcholine and cholesterol metabolisms in Alzheimer’s disease model. C. R. Biol., 2011, 334, 85-90.
[55]
Racine, R.; Gueguen, Y.; Gourmelon, P.; Veyssiere, G.; Souidi, M. Modifications of the expression of genes involved in cerebral cholesterol metabolism in the rat following chronic ingestion of depleted uranium. J. Mol. Neurosci., 2009, 38, 159-165.
[56]
Racine, R.; Grandcolas, L.; Grison, S.; Stefani, J.; Delissen, O.; Gourmelon, P.; Veyssière, G.; Souidi, M. Cholesterol 7alpha-hydroxylase (CYP7A1) activity is modified after chronic ingestion of depleted uranium in the rat. J. Steroid Biochem. Mol. Biol., 2010, 120, 60-66.
[57]
Hu, Z.; Jin, S.; Scotto, K.W. Transcriptional activation of the MDR1 gene by UV irradiation. Role of NF-Y and Sp1. J. Biol. Chem., 2000, 275, 2979-2985.
[58]
Uchiumi, T.; Kohno, K.; Tanimura, H.; Matsuo, K.; Sato, S.; Uchida, Y.; Kuwano, M. Enhanced expression of the human multidrug resistance 1 gene in response to UV light irradiation. Cell Growth Differ., 1993, 4, 147-157.
[59]
Ohga, T.; Uchiumi, T.; Makino, Y.; Koike, K.; Wada, M.; Kuwano, M.; Kohno, K. Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene. J. Biol. Chem., 1998, 273, 5997-6000.
[60]
Hsieh, C.H.; Hou, M.L.; Wang, L.Y.; Tai, H.C.; Tsai, T.H.; Chen, Y.J. Local pelvic irradiation modulates Pharmacokinetics of 5-Fluorouracil in the plasma but not in the Lymphatic System. BMC Cancer, 2015, 15, 316-324.
[61]
Hsieh, C.H.; Liu, C.Y.; Hsieh, Y.J.; Tai, H.C.; Wang, L.Y.; Tsai, T.H.; Chen, Y.J. Matrix metalloproteinase-8 mediates the unfavorable systemic impact of local irradiation on pharmacokinetics of anti-cancer drug 5-Fluorouracil. PLoS One, 2011, 6, e21000.
[62]
Hsieh, C.H.; Hou, M.L.; Chiang, M.H.; Tai, H.C.; Tien, H.J.; Wang, L.Y.; Tsai, T.H.; Chen, Y.J. Head and neck irradiation modulates pharmacokinetics of 5-fluorouracil and cisplatin. J. Transl. Med., 2013, 11, 231-241.
[63]
Hsieh, C.H.; Hsieh, Y.J.; Liu, C.Y.; Tai, H.C.; Huang, Y.C.; Shueng, P.W.; Wu, L.J.; Wang, L.Y.; Tsai, T.H.; Chen, Y.J. Abdominal irradiation modulates 5-Fluorouracil pharmacokinetics. J. Transl. Med., 2010, 8, 29-37.
[64]
Tsai, T.H.; Chen, Y.J.; Hou, M.L.; Wang, L.Y.; Tai, H.C.; Hsieh, C.H. Pelvic irradiation modulates the pharmacokinetics of cisplatin in the plasma and lymphatic system. Am. J. Transl. Res., 2015, 7, 375-384.
[65]
Qiao, Y.J.; Yang, J.X.; Yang, M.; Zhou, X.J.; Xin, Y.Y.; Nian, Y.Q.; Zhu, L.; Li, X.Y. Effects of irradiation on the metabolism of irinotecan. Chin. High. Alt. Med. Biol., 2018, 39, 102-104.
[66]
Song, X.Y. Study on the mechanism of radiation protection of 18- beta-glycyrrhizic acid. Master Thesis, Qinghai University: Xining,. 2016.
[67]
Sun, Y.; Xiao, N.; Li, G.; Han, Y.Y.; Liu, S.Y.; Wang, E.P.; Chen, C.B. A Comparative Pharmacokinetic Study of Ginsenoside Re after Oral Administration in Normal and Ultraviolet B Irradiation-induced Damage Rats. Chin. J. Anal. Chem., 2018, 46, 678-683.
[68]
Zhang, J.L.; Zhu, J.B.; Yao, X.C.; Duan, Y.B.; Zhou, X.J.; Yang, M.; Li, X.Y. Pharmacokinetics of lidocaine hydrochloride metabolized by CYP3A4 in Chinese Han volunteers living at low altitude and in native Han and Tibetan Chinese volunteers living at high altitude. Pharmacology, 2016, 97, 107-113.
[69]
Li, X.Y.; Liu, Y.N.; Wang, X. ZHU, J.B.; Yuan, M.; Li, Y.P.; Li, Y.F. Comparison of the pharmacokinetics of sulfamethoxazole in native Han and Tibetan male Chinese volunteers living at high altitude. Eur. J. Drug Metab. Pharmacokinet., 2012, 37, 263-269.
[70]
Li, X.Y.; Gao, F.; Li, Z.Q.; Guan, W.; Feng, W.L.; Ge, R.L. Comparison of the pharmacokinetics of sulfamethoxazole in male Chinese volunteers at low altitude and acute exposure to high altitude versus subjects living chronically at high altitude: An open-labeled, controlled, prospective study. Clin. Ther., 2009, 31, 2744-2754.
Related Books
Localized Micro/Nanocarriers for Programmed and On-Demand Controlled Drug Release
Mixed Polymeric Micelles for Osteosarcoma Therapy: Development and Characterization
A Comprehensive Text Book on Self-emulsifying Drug Delivery Systems
Nanomaterials: Evolution and Advancement towards Therapeutic Drug Delivery (Part II)
Nanomaterials: Evolution and Advancement Towards Therapeutic Drug Delivery (Part I)
Article Metrics
46
4